These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8003683)

  • 1. Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material.
    Clinton J; Blackman SE; Royston MC; Roberts GW
    Neuroreport; 1994 Jan; 5(4):497-500. PubMed ID: 8003683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pattern of beta-amyloid protein deposition within cortical sulci and gyri in Alzheimer's disease.
    Clinton J; Roberts GW; Gentleman SM; Royston MC
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):277-81. PubMed ID: 8355814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of cortical synaptic density in Alzheimer's disease.
    Scheff SW; DeKosky ST; Price DA
    Neurobiol Aging; 1990; 11(1):29-37. PubMed ID: 2325814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease.
    Masliah E; Hansen L; Albright T; Mallory M; Terry RD
    Acta Neuropathol; 1991; 81(4):428-33. PubMed ID: 1903014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
    Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL
    Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synapse loss in the temporal lobe in Alzheimer's disease.
    Scheff SW; Price DA
    Ann Neurol; 1993 Feb; 33(2):190-9. PubMed ID: 8434881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
    Greber S; Lubec G; Cairns N; Fountoulakis M
    Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
    Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
    J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry.
    Yao PJ; Morsch R; Callahan LM; Coleman PD
    Neuroscience; 1999; 94(2):389-94. PubMed ID: 10579202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease.
    Im K; Lee JM; Seo SW; Hyung Kim S; Kim SI; Na DL
    Neuroimage; 2008 Oct; 43(1):103-13. PubMed ID: 18691657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
    Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC
    Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A
    Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
    Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P
    J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.
    Brinkmalm A; Brinkmalm G; Honer WG; Frölich L; Hausner L; Minthon L; Hansson O; Wallin A; Zetterberg H; Blennow K; Öhrfelt A
    Mol Neurodegener; 2014 Nov; 9():53. PubMed ID: 25418885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.
    Masliah E; Terry RD; DeTeresa RM; Hansen LA
    Neurosci Lett; 1989 Aug; 103(2):234-9. PubMed ID: 2505201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
    Masliah E; Terry RD; Alford M; DeTeresa R; Hansen LA
    Am J Pathol; 1991 Jan; 138(1):235-46. PubMed ID: 1899001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical variability and asymmetry in normal aging and Alzheimer's disease.
    Thompson PM; Moussai J; Zohoori S; Goldkorn A; Khan AA; Mega MS; Small GW; Cummings JL; Toga AW
    Cereb Cortex; 1998 Sep; 8(6):492-509. PubMed ID: 9758213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
    Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
    Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay.
    Siew LK; Love S; Dawbarn D; Wilcock GK; Allen SJ
    J Neurosci Methods; 2004 Oct; 139(2):153-9. PubMed ID: 15488227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease.
    Gentleman SM; Allsop D; Bruton CJ; Jagoe R; Polak JM; Roberts GW
    Neurosci Lett; 1992 Feb; 136(1):27-30. PubMed ID: 1635663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.